Inventor · disambiguated record
Herbert Y. Meltzer
Also filed as: MELTZER HERBERT · MELTZER HERBERT Y
10 granted patents·4 pending applications·47 citations·filing 1991–2023
86Inventor score
Top patents by PatentIndex Score
14 records- 0195US10654865B2Enantioselective syntheses of heteroyohimbine natural product intermediatesUNIV NORTHWESTERN·Filed 2019·Granted May 19, 2020·7 cites·7 claims
- 0295US10323039B2Enantioselective syntheses of heteroyohimbine natural product intermediatesUNIV NORTHWESTERN·Filed 2016·Granted Jun 18, 2019·11 cites·5 claims
- 0387US11174514B2Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and treating psychiatric disorders in a patientUNIV NORTHWESTERN·Filed 2015·Granted Nov 16, 2021·3 cites·12 claims
- 0480US10098893B2Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457UNIV NORTHWESTERN·Filed 2014·Granted Oct 16, 2018·2 cites·11 claims
- 0576US2023386637A1Polymorphisms for Predicting Treatment Response to Antipsychotic Drugs and Identifying New Drug TargetsUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 0673US12410474B2Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patientUNIV NORTHWESTERN·Filed 2021·Granted Sep 9, 2025·0 cites·8 claims
- 0764US2023265093A1Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)UNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 0861US11485734B2Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT2C)UNIV NORTHWESTERN·Filed 2019·Granted Nov 1, 2022·0 cites·16 claims
- 0961US2019264285A1Polymorphisms for predicting treatment response to antipsychotic drugs and idenfying new drug targetsUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 1055US5300422AScreening method for controlling agranulocytosisUNIV CASE WESTERN RESERVE·Filed 1991·Granted Apr 5, 1994·19 cites·14 claims
- 1147US2019351006A1Methods of administration of nmda receptor agonistsNAUREX INC·Filed 2018·Application pending·0 cites
- 1244US11666547B2Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)UNIV NORTHWESTERN·Filed 2020·Granted Jun 6, 2023·0 cites·26 claims
- 1335US5221679AMethod of treating therapy resistant schizophrenia with melperone (R-fluoro-Y-methyl-peperidino-butyrophrenone)UNIV CASE WESTERN RESERVE·Filed 1992·Granted Jun 22, 1993·5 cites·5 claims
- 1431US8735397B2Method for treating schizophrenia and related diseasesMELTZER HERBERT Y·Filed 2011·Granted May 27, 2014·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →